The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

Pin to quick picksIWG Regulatory News (IWG)

Share Price Information for IWG (IWG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 186.20
Bid: 186.40
Ask: 186.60
Change: 2.40 (1.31%)
Spread: 0.20 (0.107%)
Open: 182.50
High: 188.70
Low: 182.50
Prev. Close: 183.80
IWG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - IWG PLC

25 Jun 2018 13:34

Norges Bank - Form 8.3 - IWG PLC

Norges Bank - Form 8.3 - IWG PLC

PR Newswire

London, June 25

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:Norges Bank
(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.N/A
(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeIWG PLC
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:N/A
(e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosureDealing Disclosure 22/06/2018
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A”No Not Required

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:1P ordinary
InterestsShort positions
Number%Number%
(1) Relevant securities owned and/or controlled:19,542,5592.14
(2) Cash-settled derivatives:
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:
TOTAL:19,542,5592.14

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

Purchases and sales

Class of relevant securityPurchase/saleNumber of securitiesPrice per unit
1P ordinarySell85,020GBP 3.1644

(b) Cash-settled derivative transactions

Class of relevant securityProduct description e.g. CFDNature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitType e.g. American, European etc.Expiry dateOption money paid/ received per unit

(ii) Exercise

Class of relevant securityProduct description e.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant securityNature of dealing e.g. subscription, conversionDetailsPrice per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state “none”

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?NO

Date of disclosure:25/06/2018
Contact name:Philippe Chiaroni
Telephone number:+47 2407 3297

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Date   Source Headline
7th Jun 20217:00 amRNSTrading Update
1st Jun 20212:34 pmRNSTotal Voting Rights: Month End Disclosure
11th May 20212:00 pmRNSRESULTS OF ANNUAL GENERAL MEETING
7th May 20212:00 pmRNS2021 Annual General Meeting
4th May 20217:00 amRNSTotal Voting Rights: Month End Disclosure
27th Apr 20217:00 amRNSTrading Update
8th Apr 20215:00 pmRNSAnnual Report and Accounts, and AGM
1st Apr 20217:00 amRNSTotal Voting Rights: Month End Disclosure
31st Mar 202110:00 amRNSDirector/PDMR Transaction
26th Mar 20215:36 pmRNSDirector/PDMR Transaction
26th Mar 20215:36 pmRNSDirector/PDMR Transaction
25th Mar 20217:00 amRNSAppointment of Chief Financial Officer
9th Mar 20217:00 amRNSFull Year Results
1st Mar 20218:53 amRNSTotal Voting Rights
1st Feb 20217:00 amRNSTotal Voting Rights: Month End Disclosure
20th Jan 20217:00 amRNSYear End Trading Update
4th Jan 20217:00 amRNSTotal Voting Rights: Month End Disclosure
21st Dec 20209:21 amRNSResults of Extraordinary General Meeting
3rd Dec 20202:40 pmRNSNotice of Extraordinary General Meeting & Circular
2nd Dec 20204:29 pmRNSConvertible Bond Offering
2nd Dec 202012:46 pmRNSStandard form for notification of major holdings
2nd Dec 20207:00 amRNSConvertible Bond Offering
1st Dec 20209:29 amRNSTotal Voting Rights: Month End Disclosure
11th Nov 202010:04 amRNSDirector/PDMR Transaction
3rd Nov 20207:00 amRNSThird Quarter Trading Statement
2nd Nov 20208:00 amRNSTotal Voting Rights: Month End Disclosure
1st Oct 20207:00 amRNSTotal Voting Rights: Month End Disclosure
1st Sep 20201:17 pmRNSStandard form for notification of major holdings
1st Sep 20209:56 amRNSTotal Voting Rights: Month End Disclosure
17th Aug 20209:04 amRNSStandard form for notification of major holdings
4th Aug 20204:16 pmRNSTotal Voting Rights: Month End Disclosure
4th Aug 20207:00 amRNS2019 Interim Results
1st Jul 202010:05 amRNSTotal Voting Rights: Month End Disclosure
1st Jun 20203:09 pmRNSDirector/PDMR Shareholding Notification
1st Jun 20209:12 amRNSTotal Voting Rights: Month End Disclosure
29th May 20203:55 pmRNSTransaction notification
29th May 20203:55 pmRNSTransaction notification
28th May 20205:30 pmRNSIWG
28th May 20207:00 amRNSResults of Placing
27th May 20205:13 pmRNSRetail Offer via PrimaryBid.com
27th May 20205:09 pmRNSProposed Placing of New Ordinary Shares
27th May 20205:07 pmRNSTrading Update
12th May 20202:22 pmRNSResult of AGM
11th May 20209:42 amRNS2020 Annual General Meeting
1st May 20209:42 amRNSTotal Voting Rights: Month End Disclosure
9th Apr 20204:21 pmRNSAnnual Report and Accounts, and AGM
6th Apr 20207:00 amRNSAmendment to date of Q1 Trading Update
3rd Apr 20202:42 pmRNSStandard form for notification of major holdings
2nd Apr 20208:00 amRNSStandard form for notification of major holdings
2nd Apr 20208:00 amRNSStandard form for notification of major holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.